NCT00868803View on ClinicalTrials.gov

Aberrant Gene Expression Prostate Carcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

April 30, 1995

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Prostate Cancer
Trial Locations (1)

01805

Lahey Clinic, Burlington

Sponsors

Lead Sponsor

Lahey Clinic
All Listed Sponsors
lead

Lahey Clinic

OTHER